AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
AAPL   331.50 (+2.85%)
MSFT   187.20 (+2.34%)
FB   230.77 (+1.98%)
GOOGL   1,440.02 (+1.82%)
AMZN   2,483.00 (+0.91%)
NVDA   356.80 (+1.75%)
CGC   16.51 (-0.72%)
BABA   219.55 (+0.69%)
MU   53.72 (+4.88%)
GE   7.88 (+1.81%)
TSLA   885.66 (+2.46%)
AMD   53.10 (+0.89%)
T   32.77 (+3.05%)
ACB   13.94 (-2.04%)
F   7.34 (+5.46%)
GILD   76.75 (-1.02%)
DIS   124.82 (+0.91%)
NFLX   419.60 (+1.27%)
BAC   28.11 (+4.97%)
BA   205.43 (+11.47%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Odonate TherapeuticsY-mAbs TherapeuticsAimmune TherapeuticsRevance TherapeuticsIntra-Cellular Therapies
SymbolNASDAQ:ODTNASDAQ:YMABNASDAQ:AIMTNASDAQ:RVNCNASDAQ:ITCI
Price Information
Current Price$35.53$43.04$17.98$22.51$21.59
52 Week RangeSellBuyBuyBuyBuy
Beat the Market™ Rank
Overall Score1.01.52.41.71.5
Analysis Score0.52.44.34.43.5
Community Score2.12.53.02.62.6
Dividend Score0.00.00.00.00.0
Ownership Score2.02.04.01.01.0
Earnings & Valuation Score0.60.60.60.60.6
Analyst Ratings
Consensus RecommendationSellBuyBuyBuyBuy
Consensus Price Target$26.00$44.60$40.09$28.63$37.13
% Upside from Price Target-26.82% downside3.62% upside122.98% upside27.19% upside71.95% upside
Trade Information
Market Cap$1.22 billion$1.68 billion$1.20 billion$1.26 billion$1.38 billion
Beta1.111.380.971.561.86
Average Volume75,865231,6801,543,903806,0311,150,661
Sales & Book Value
Annual RevenueN/AN/AN/A$410,000.00$60,000.00
Price / SalesN/AN/AN/A3,131.6023,911.28
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$5.06 per share$5.01 per share$1.66 per share$5.00 per share$3.52 per share
Price / BookN/AN/AN/A4.506.13
Profitability
Net Income$-111,820,000.00$-81,030,000.00$-248,500,000.00$-159,430,000.00$-147,720,000.00
EPS($4.05)($2.30)($3.97)($3.67)($2.68)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)-67.21%-64.21%-155.39%-85.18%-57.81%
Return on Assets (ROA)-58.26%-57.03%-92.41%-49.78%-48.47%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.01%0.59%0.64%0.05%
Current Ratio6.28%12.79%8.10%12.45%14.83%
Quick Ratio6.28%12.79%8.01%12.45%14.79%
Ownership Information
Institutional Ownership Percentage95.78%50.47%71.85%86.63%72.25%
Insider Ownership Percentage48.90%38.40%13.75%4.80%18.20%
Miscellaneous
Employees1173222817073
Shares Outstanding32.11 million39.76 million65.25 million57.05 million66.45 million
Next Earnings Date7/22/2020 (Estimated)8/12/2020 (Estimated)8/13/2020 (Estimated)8/3/2020 (Estimated)8/5/2020 (Estimated)
OptionableNot OptionableNot OptionableOptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.